The t(1,12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion

被引:71
作者
Salomon-Nguyen, F
Della-Valle, V
Mauchauffé, M
Busson-Le Coniat, M
Ghysdael, J
Berger, R
Bernard, OA
机构
[1] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, INSERM, U434, F-75010 Paris, France
[2] CNRS, UMR 146, F-91405 Orsay, France
关键词
D O I
10.1073/pnas.120162297
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The TEL/ETV6 gene is located at 12p13 and encodes a member of the ETS family of transcription factors. Translocated ETS leukemia (TEL) is frequently involved in chromosomal translocations in human malignancies, usually resulting in the expression of fusion proteins between the amino-terminal part of TEL and either unrelated transcription factors or protein tyrosine kinases, We have characterized a t(1;12)(q21;p13) translocation in an acute myeloblastic leukemia (AML-M2). At the protein level, the untranslocated TEL copy and, as a result of the t(1;12) translocation. a fusion protein between TEL and essentially all of aryl hydrocarbon receptor nuclear translocator (ARNT) are expressed. The involvement of ARNT in human leukemogenesis has not been previously described, The ARNT protein belongs to a subfamily of the "basic region helix-loop-helix" (bHLH) protein that shares an additional region of similarity called the PAS (Per. ARNT. SIM) domain. ARNT is the central partner of several heterodimeric transcription factors, including those containing the aryl hydrocarbon (dioxin) receptor (AhR) and the hypoxia-inducible factor 1 alpha (HIF1 alpha). Our results show that the TEL-ARNT fusion protein is the crucial product of the translocation and suggest that interference with the activity of AhR or HIF1 alpha can contribute to leukemogenesis.
引用
收藏
页码:6757 / 6762
页数:6
相关论文
共 41 条
[1]   Multilineage embryonic hematopoiesis requires hypoxic ARNT activity [J].
Adelman, DM ;
Maltepe, E ;
Simon, MC .
GENES & DEVELOPMENT, 1999, 13 (19) :2478-2483
[2]   Chromosome abnormalities of the short arm of chromosome 12 in hematopoietic malignancies: a report including three novel translocations involving the TEL/ETV6 gene [J].
Berger, R ;
LeConiat, M ;
Lacronique, V ;
Daniel, MT ;
Lessard, M ;
Berthou, C ;
Marynen, P ;
Bernard, O .
LEUKEMIA, 1997, 11 (09) :1400-1403
[3]  
Bergsagel DE, 1999, BLOOD, V94, P1174
[4]  
BERNARD OA, 1994, ONCOGENE, V9, P1039
[5]  
BUIJS A, 1995, ONCOGENE, V10, P1511
[6]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[7]   The TEL platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways [J].
Carroll, M ;
Tomasson, MH ;
Barker, GF ;
Golub, TR ;
Gilliland, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14845-14850
[8]   Control of cell lineage-specific development and transcription by bHLH-PAS proteins [J].
Crews, ST .
GENES & DEVELOPMENT, 1998, 12 (05) :607-620
[9]   Oncogenic alterations of metabolism [J].
Dang, CV ;
Semenza, GL .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) :68-72
[10]   Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25) [J].
Eguchi, M ;
Eguchi-Ishimae, M ;
Tojo, A ;
Morishita, K ;
Suzuki, K ;
Sato, Y ;
Kudoh, S ;
Tanaka, K ;
Setoyama, M ;
Nagamura, F ;
Asano, S ;
Kamada, N .
BLOOD, 1999, 93 (04) :1355-1363